Parallax Volatility Advisers
COLL icon

Parallax Volatility Advisers’s Collegium Pharmaceutical COLL Stock Holding History

Parallax Volatility Advisers’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,444
Closed -$64K – 2486
2017
Q4 		$64K Buy
+3,444
New +$49.3K ﹤0.01% 3072

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Parallax Volatility Advisers's COLL Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of Collegium Pharmaceutical (COLL) in Q1 2018, closing a stake of 3,444 shares — an estimated $64K sold.

Parallax Volatility Advisers first reported a position in COLL in Q4 2017 and held it in 1 quarter. The position peaked at $64K in Q4 2017. 140 funds tracked by Wall St. Rank hold COLL as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining Collegium Pharmaceutical position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 3,444 Collegium Pharmaceutical shares in Q1 2018, an estimated $64K.
  • Parallax Volatility Advisers first reported a position in Collegium Pharmaceutical in Q4 2017 and held it in 1 quarter.
  • Parallax Volatility Advisers's Collegium Pharmaceutical position peaked at $64K in Q4 2017.
  • 140 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.